Immuron Limited (IMRN) News

Immuron Limited (IMRN): $1.71

0.00 (0.23%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add IMRN to Watchlist
Sign Up

Filter IMRN News Items

IMRN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest IMRN News From Around the Web

Below are the latest news stories about IMMURON LTD that investors may wish to consider to help them evaluate IMRN as an investment opportunity.

UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held December 5th are now available for online viewing. REGISTER NOW AT: https://bit.ly/49lNzqK The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts ma

Yahoo | December 6, 2024

Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Small Cap Growth Virtual Investor Conference to be held December 5th. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/49lNzqK It is recommended that investors pre-register and ru

Yahoo | December 6, 2024

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing. Participants and those ...

Yahoo | December 3, 2024

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

MELBOURNE, Australia, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com on Thursday 5th December 2024 (2.30pm U.S. Eastern time). Immuron invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com DATE: December 5thTIME: 2

Yahoo | December 2, 2024

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore presented early this morning at the 21st Virtual Investor Summit Microcap Event (November 21, US Eastern Time). A copy of the presentation is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ This release has been authorised by the directors of Immuron Limited. COMPANY CONTACT: Steven LydeamoreChi

Yahoo | November 21, 2024

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 /Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated diseases. The company will be available for 1-on-1 ...

Yahoo | November 18, 2024

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp

Yahoo | October 29, 2024

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

MELBOURNE, Australia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be participating in a fireside chat at the Maxim Virtual Healthcare Conference on Wednesday, 16th October 2024 (4.30pm U.S. Eastern time). A copy of the presentation covering information being discussed is available on the Company’s website. https://www.immuron.com.au/corporate-presentations/ This release has been authorised by t

Yahoo | October 16, 2024

Immuron Travelan® continued strong sales growth

Sales Highlights: Global• September 2024 Quarter AUD$1.5 million up 13% on prior quarter Australia• September 2024 Quarter AUD$1.0 million up 3% on prior quarter NorthAmerica• September 2024 Quarter AUD$0.5 million up 48% on prior quarter MELBOURNE, Australia, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued strong sales growth (unaudited) of Travelan®, an over-the-co

Yahoo | October 15, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

MELBOURNE, Australia, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases. Following discussion with the US Naval Medical Research Command (NMRC), today the Company can announce that the NMRC has completed the interim analysis for the clinical evaluation of a new oral therapeutic t

Yahoo | October 4, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!